How effective is the RSV vaccine during pregnancy and how does it work?

Translate to Spanish or other 102 languages!

How safe and effective is the RSV vaccine during pregnancy? Image for illustration purposes
How safe and effective is the RSV vaccine during pregnancy? Image for illustration purposes
- Advertisement -
  • RSV is a respiratory virus affecting about 64 million people around the world each year. 
  • While RSV symptoms may only feel like a common cold to adults and older children, it can be much more serious in older adults, babies, and young children. 
  • About 1.4 million children ages 0 to 6 months are hospitalized from RSV each year.
  • The CDC and American College of Obstetricians and Gynecologists both recommend pregnant people receive an RSV vaccine to help immunize their babies from the disease before they are born. 

Respiratory syncytial virus (RSV) is a respiratory virus causing infection in the lungs, nose, and throat.

Follow the link below to Medical News Today to read the full Story: 

https://www.medicalnewstoday.com/articles/how-safe-effective-is-rsv-vaccine-during-pregnancy

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -